[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

DK584375A - Fremgangsmade til forbedring af intravenoskompabiliteten af gammaglobuliner - Google Patents

Fremgangsmade til forbedring af intravenoskompabiliteten af gammaglobuliner

Info

Publication number
DK584375A
DK584375A DK584375A DK584375A DK584375A DK 584375 A DK584375 A DK 584375A DK 584375 A DK584375 A DK 584375A DK 584375 A DK584375 A DK 584375A DK 584375 A DK584375 A DK 584375A
Authority
DK
Denmark
Prior art keywords
intravenos
compatibility
improving
procedure
gamma globulins
Prior art date
Application number
DK584375A
Other languages
English (en)
Other versions
DK144679C (da
DK144679B (da
Inventor
W Schneider
D Wolter
Original Assignee
Ratiopharma Anstalt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ratiopharma Anstalt filed Critical Ratiopharma Anstalt
Publication of DK584375A publication Critical patent/DK584375A/da
Publication of DK144679B publication Critical patent/DK144679B/da
Application granted granted Critical
Publication of DK144679C publication Critical patent/DK144679C/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
DK584375A 1975-01-02 1975-12-22 Fremgangsmaade til udvinding af intravenoeskompatible gammaglobuliner DK144679C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2500076A DE2500076C3 (de) 1975-01-02 1975-01-02 Verfahren zur Gewinnung von intravenös-verträglichen Gammaglobulinen
DE2500076 1975-01-02

Publications (3)

Publication Number Publication Date
DK584375A true DK584375A (da) 1976-07-03
DK144679B DK144679B (da) 1982-05-10
DK144679C DK144679C (da) 1982-10-11

Family

ID=5935911

Family Applications (1)

Application Number Title Priority Date Filing Date
DK584375A DK144679C (da) 1975-01-02 1975-12-22 Fremgangsmaade til udvinding af intravenoeskompatible gammaglobuliner

Country Status (20)

Country Link
JP (1) JPS5512001B2 (da)
AT (1) AT344883B (da)
AU (1) AU505416B2 (da)
BE (1) BE837211A (da)
CA (1) CA1058075A (da)
DD (1) DD121875A5 (da)
DE (1) DE2500076C3 (da)
DK (1) DK144679C (da)
EG (1) EG11987A (da)
ES (1) ES443982A1 (da)
FR (1) FR2296429A1 (da)
GB (1) GB1495159A (da)
IE (1) IE43449B1 (da)
IL (1) IL48766A (da)
IN (1) IN143525B (da)
NL (1) NL179824C (da)
PL (1) PL99599B1 (da)
SE (1) SE437470B (da)
SU (1) SU576898A3 (da)
ZA (1) ZA758050B (da)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2604759C2 (de) * 1976-02-07 1983-06-01 SCHURA Blutderivate GmbH & Co KG, 4150 Krefeld Verfahren zur Gewinnung von iv-verträglichen Γglobulinen
JPS6016406B2 (ja) * 1976-08-06 1985-04-25 マイヤ−、ル−イス、コ−バル 静脈内に投与可能なガンマ・グロブリンの製造法ならびにそれにより調製したガンマ・グロブリン
US4124576A (en) * 1976-12-03 1978-11-07 Coval M L Method of producing intravenously injectable gamma globulin
GB1603244A (en) * 1977-05-20 1981-11-18 Max Planck Gesellschaft Medicaments for the suppression of pathological processes
JPS5822085B2 (ja) * 1977-07-19 1983-05-06 株式会社ミドリ十字 静注用ガンマ・グロブリン製剤
AT359641B (de) 1978-09-19 1980-11-25 Immuno Ag Verfahren zur herstellung eines intravenoes ver- abreichbaren antikoerperhaeltigen immunglobulin- praeparates
EP0019403B1 (en) * 1979-05-10 1985-07-31 American Hospital Supply Corporation Hydroxyalkyl-starch drug carrier
US4396608A (en) * 1981-08-24 1983-08-02 Cutter Laboratories Intravenously injectable immune serum globulin
ATE19735T1 (de) * 1982-02-08 1986-05-15 Schweiz Serum & Impfinst Intravenoes verabreichbares humanes immunglobulin und verfahren zu dessen herstellung.
US4482483A (en) * 1983-04-06 1984-11-13 Armour Pharmceutical Company Composition of intravenous immune globulin
SE8302483L (sv) * 1983-05-02 1984-11-03 Pharmacia Ind Forfarande vid rening av biologiskt aktiva substanser
US5945098A (en) * 1990-02-01 1999-08-31 Baxter International Inc. Stable intravenously-administrable immune globulin preparation
DE19907257A1 (de) * 1999-02-21 2000-09-14 Bernd Horst Meier Mittel zur Steuerung der Diffusion von Injektionslösungen
DE10040707A1 (de) * 2000-08-17 2002-03-14 Braun Melsungen Ag Kolloidale Pharmakomodulation injizierter Arzneimittel
DE10303974A1 (de) 2003-01-31 2004-08-05 Abbott Gmbh & Co. Kg Amyloid-β(1-42)-Oligomere, Verfahren zu deren Herstellung und deren Verwendung
IL297746A (en) 2005-11-30 2022-12-01 Abbvie Inc Monoclonal antibodies against amyloid beta protein and uses thereof
ES2524984T3 (es) 2005-11-30 2014-12-16 Abbvie Inc. Anticuerpos anti-globulómero a?, porciones de unión a antígeno de estos, hibridomas correspondientes, ácidos nucleicos, vectores, células huésped, métodos para producir dichos anticuerpos, composiciones que comprenden dichos anticuerpos, usos de dichos anticuerpos, y métodos para usar dichos anticuerpos
US8455626B2 (en) 2006-11-30 2013-06-04 Abbott Laboratories Aβ conformer selective anti-aβ globulomer monoclonal antibodies
EP2486928A1 (en) 2007-02-27 2012-08-15 Abbott GmbH & Co. KG Method for the treatment of amyloidoses
US8987419B2 (en) 2010-04-15 2015-03-24 AbbVie Deutschland GmbH & Co. KG Amyloid-beta binding proteins
CA2808187A1 (en) 2010-08-14 2012-02-23 Abbvie Inc. Amyloid-beta binding proteins

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE348942B (da) * 1970-06-02 1972-09-18 Statens Bakteriologiska Labor
DE2234069A1 (de) * 1971-07-16 1973-02-08 South African Inventions Verfahren zur herstellung eines gereinigten gamma-globulins
IL43643A (en) * 1972-11-27 1976-10-31 Baxter Laboratories Inc Method for production of gamma globulin
JPS49101516A (da) * 1973-01-13 1974-09-25

Also Published As

Publication number Publication date
AT344883B (de) 1978-08-10
IE43449B1 (en) 1981-02-25
IL48766A0 (en) 1976-02-29
AU505416B2 (en) 1979-11-22
FR2296429B1 (da) 1978-12-01
JPS5512001B2 (en) 1980-03-29
JPS5191321A (en) 1976-08-10
BE837211A (fr) 1976-06-30
SU576898A3 (ru) 1977-10-15
ZA758050B (en) 1976-12-29
NL179824C (nl) 1986-11-17
IE43449L (en) 1976-07-02
GB1495159A (en) 1977-12-14
DK144679C (da) 1982-10-11
DD121875A5 (da) 1976-09-05
PL99599B1 (pl) 1978-07-31
DE2500076A1 (de) 1976-07-08
ES443982A1 (es) 1977-07-16
IN143525B (da) 1977-12-17
SE437470B (sv) 1985-03-04
DE2500076B2 (de) 1979-02-22
NL7514627A (nl) 1976-07-06
NL179824B (nl) 1986-06-16
CA1058075A (en) 1979-07-10
ATA981675A (de) 1977-12-15
IL48766A (en) 1979-11-30
FR2296429A1 (fr) 1976-07-30
DK144679B (da) 1982-05-10
DE2500076C3 (de) 1982-11-18
SE7514388L (sv) 1976-07-05
AU8792175A (en) 1977-07-14
EG11987A (en) 1981-12-31

Similar Documents

Publication Publication Date Title
DK487476A (da) Fremgangsmade til fremstilling af imidazolidiner
DK49676A (da) Fremgangsmade til fremstilling af hypolipidemiske midler
DK424476A (da) Fremgangsmade til fremstilling af svovlholdige organosiliciumforbindelser
DK148907C (da) Analogifremgangsmaade til fremstilling af dihydrocyclosporin c
DK584375A (da) Fremgangsmade til forbedring af intravenoskompabiliteten af gammaglobuliner
DK136398C (da) Fremgangsmaade til fremstilling af et analgetisk-antipyretisk praeparat
DK593975A (da) Fremgangsmade til fremstilling af substituerede perhalogenalkylamidiner
DK107876A (da) Fremgangsmade til fremstilling af thiocarbamider
DK535476A (da) Fremgangsmade til fremstilling af 7-methoxycephalosporiner
DK150676A (da) Fremgangsmade til fremstilling af krystallinsk natrium-o-formyl-cefamandol
DK148139C (da) Analogifremgangsmaade til fremstilling af 5-benzyl-2-oxazolidonderivater
DK387876A (da) Fremgangsmade til fremstilling af oxazolidinoner
DK146629C (da) Analogifremgangsmaade til fremstilling af depotsteroidestere
DK399976A (da) Fremgangsmade til fremstilling af aralkylamider
DK415576A (da) Fremgangsmade til fremstilling af krystallinsk dipilocarpiniumpamoat
DK484676A (da) Fremgangsmade til fremstilling af aroyl-phenyliden- eller aroyl-phenylnaphthalenforbindelser
DK141584C (da) Fremgangsmaade til fremstilling af slagseje vinylaromat-podecopolymere
DK526676A (da) Fremgangsmade til fremstilling af 4-chlor-2-butynyl-m-chlorcarbanilat
DK424676A (da) Fremgangsmade til fremstilling af 2-alkylindan
DK480676A (da) Fremgangsmade til fremstilling af s-alkylphosphordihalogeniddithioater
DK401476A (da) Fremgangsmade til fremstilling af benzocycloheptapyridinforbindelser
DK46476A (da) Fremgangsmade til fremstilling af 5-nitrothiazolylimidazolidiner
DK551176A (da) Fremgangsmade til fremstilling af trifluormethylthio- og trifluormethylsulfonyl-thioxanthen-9-ylidenpiperaziner
DK579776A (da) Fremgangsmade til fremstilling af 7-methoxy-cephalosporiner
DK55476A (da) Fremgangsmade til fremstilling af dinitronaphthalener